http://www.clinicaltrialsarena.com/news/alnylams-kardia-1-trial-meets-primary-endpoint-in-hypertension/
0
0
11/14/23 at 3:12pm
Organization
Clinical Trials Arena
Author
Joshua Silverwood
Alnylam has announced positive results from its Phase II study of zilebesiran for the treatment of patients with hypertension.
Create an account
or login to join the discussion